Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting cell-cycle machinery in cancer

Cancer Cell(2021)10.1016/j.ccell.2021.03.010Source: DataRank Database

Targeting cell-cycle machinery in cancer is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 571 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access571 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 50.59)OA: bronzeTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Marcin Braun ORCID,Vladislav Strmiska ORCID,Piotr Siciński ORCID,Jan M. Suski ORCID

Live enrichment

PubMed:33891890 PMC:PMC8206013 OpenAlex:https://openalex.org/W3156721991

National Institutes of Health

Grant: P50CA168504

National Institutes of Health

Grant: R01CA202634

National Institutes of Health

Grant: R01CA236226

National Institutes of Health

Grant: R01CA247375

Narodowa Agencja Wymiany Akademickiej

Grant: PPN/WAL/2019/1/00023

Novartis

Fundacja na rzecz Nauki Polskiej

FWCI

50.59

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610821001689/pdf

publisherhttp://www.cell.com/article/S1535610821001689/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001689?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821001689?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2021.03.010

Fields of Study

Advanced Breast Cancer TherapiesCancer-related Molecular PathwaysChronic Lymphocytic Leukemia ResearchAnimalsAntineoplastic AgentsCell CycleCyclin DCyclin ECyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6HumansMiceMolecular Targeted TherapyNeoplasms

MeSH Terms

AnimalsAntineoplastic AgentsCell CycleHumansNeoplasmsCyclin ECyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6MiceCyclin DMolecular Targeted Therapy

Keywords

Cell cycleCarcinogenesisCell Cycle ProteinCancer cellBiologyCellCell biologyCell divisionCancerCell cycle checkpointCancer researchComputational biologyBiochemistryGenetics

Sustainable Development Goals

SDG 0: Good health and well-being